Needham & Company Defends Green Dot (GDOT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
UPDATE: Citi Downgrades Green Dot (GDOT) to Sell
December 19, 2019 8:38 AM EST(Updated - December 19, 2019 9:12 AM EST)
(update comment)
Citi analyst Andrew Schmidt downgraded Green Dot (NYSE: GDOT) from Neutral to Sell with a price target of $21.00 (from $27.00).
The analyst comments "We are downgrading GDOT to Sell following the unexpected CEO... More
After-Hours Movers 12/18: (AMPE) (NBEV) (MU) Higher; (NERV) (MLHR) (GDOT) Lower (more...)
December 18, 2019 5:43 PM ESTToday's After-Hours Movers
Minerva Neurosciences, Inc. (NASDAQ: NERV) 27.4% LOWER; Neither dose of MIN-117 tested in this trial showed a statistically significant separation from placebo on the reduction in the symptoms of MDD over the 6-week treatment period as measured by the change in the MADRS. In addition, neither dose showed a statistically significant separation from placebo on the key secondary endpoint, reduction of symptoms of anxiety as measured by Hamilton Anxiety Rating Scale (HAM-A) over the 6-week treatment period. Patients treated with the 2.5 mg dose experienced an improvement of 1.6 points... More
Green Dot (GDOT) Announces Retirement of Founder & CEO Steve Streit, Reaffirms Outlook
December 18, 2019 4:23 PM ESTGreen Dot Corporation (NYSE: GDOT) (the Company) today announced the retirement of Green Dot CEO and Founder, Steve Streit. Mr. Streit will also retire from Green Dots Holding Company Board and as Chairman of the Green Dot Bank board. Mr. Streits retirement initiates an orderly management succession and transition process under which Mr. Streit will transition to the role of Chief Innovation Officer as an independent advisor while Green Dot Board Chairman, William I. Jacobs, will serve as interim Chief Executive Officer and J. Christopher Brewster, Chair of the Audit Committee, will serve as... More



